Health & Fitness
Health and FitnessHealth and Fitness 
Wed, March 30, 2011
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - WOPRAI
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
[ Wed, Mar 30th 2011
] - Market Wire
Tue, March 29, 2011
[ Tue, Mar 29th 2011
] - Market Wire
[ Tue, Mar 29th 2011
] - Market Wire
[ Tue, Mar 29th 2011
] - Market Wire
[ Tue, Mar 29th 2011
] - Market Wire
[ Tue, Mar 29th 2011
] - Market Wire
[ Tue, Mar 29th 2011
] - WOPRAI
[ Tue, Mar 29th 2011
] - WOPRAI
[ Tue, Mar 29th 2011
] - WOPRAI
[ Tue, Mar 29th 2011
] - WOPRAI
[ Tue, Mar 29th 2011
] - WOPRAI
[ Tue, Mar 29th 2011
] - WOPRAI
[ Tue, Mar 29th 2011
] - Market Wire
[ Tue, Mar 29th 2011
] - Market Wire
[ Tue, Mar 29th 2011
] - Market Wire
Covidien plc informar os resultados do segundo trimestre no dia 21 de abril de 2011
DUBLIN--([ BUSINESS WIRE ])--A Covidien plc (NYSE: COV) informar os resultados do segundo trimestre no dia 21 de abril de 2011, antes do incio das atividades da Bolsa. A Empresa realizar uma teleconferncia com seus investidores s 8h30min, horrio na Costa Leste dos EUA. possvel acessar a chamada das seguintes maneiras:
- No website da Covidien: [ http://investor.covidien.com ].
- Por telefone: para participantes que vo somente ouvir e os que desejam participar na parte de perguntas e respostas da chamada, o nmero para os participantes nos EUA © 800-591-6923. Para os participantes fora dos Estados Unidos, o nmero © +1 617-614-4907. Para ambos os nmeros, o cdigo de acesso © 50679692.
- Por retransmisso: uma retransmisso da teleconferncia estar disponvel a partir das 11h30min no dia 21 de abril de 2011, at© s 5h do dia 28 de abril de 2011. O nmero de discagem para os participantes nos EUA © 888-286-8010. Para os participantes fora dos Estados Unidos, o nmero da discagem para ouvir a retransmisso © +1 617-801-6888. Para todos os participantes, o cdigo de acesso © 96784566.
SOBRE A COVIDIEN
A Covidien © uma empresa lder mundial em produtos de assistncia m©dica que cria solues m©dicas inovadoras para que os pacientes alcancem melhores resultados e que entrega valor atrav©s da liderana e excelncia clnicas. A Covidien produz, distribui e atende uma ampla diversidade de linhas de produtos lderes do setor em trs segmentos: Dispositivos M©dicos, Produtos Farmacuticos e Suprimentos M©dicos. Com uma receita de US$ 10,4 bilhes em 2010, a Covidien tem aproximadamente 42 mil funcionrios mundialmente em mais de 60 pases, e seus produtos so vendidos em mais de 140 pases. Acesse o site [ www.covidien.com ] para obter informaes adicionais sobre os nossos negcios.
O texto no idioma original deste anncio © a verso oficial autorizada. As tradues so fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que © a nica verso do texto que tem efeito legal.